169 related articles for article (PubMed ID: 11821099)
1. Administration of an antiprogesterone up-regulates estrogen receptors in the endometrium of women using Norplant: a pilot study.
Glasier AF; Wang H; Davie JE; Kelly RW; Critchley HO
Fertil Steril; 2002 Feb; 77(2):366-72. PubMed ID: 11821099
[TBL] [Abstract][Full Text] [Related]
2. The effect of transdermal oestradiol on bleeding pattern, hormonal profiles and sex steroid receptor distribution in the endometrium of Norplant users.
Boonkasemsanti W; Reinprayoon D; Pruksananonda K; Niruttisard S; Triratanachat S; Leepipatpaiboon S; Wannakrairot P
Hum Reprod; 1996 Oct; 11 Suppl 2():115-23. PubMed ID: 8982753
[TBL] [Abstract][Full Text] [Related]
3. Immunolocalization of endothelin and neutral endopeptidase in the endometrium of users of subdermally implanted levonorgestrel (Norplant).
Marsh MM; Butt AR; Riley SC; Rogers PA; Susil B; Affandi B; Findlay JK; Salamonsen LA
Hum Reprod; 1995 Oct; 10(10):2584-9. PubMed ID: 8567775
[TBL] [Abstract][Full Text] [Related]
4. Effect of levonorgestrel and mifepristone on endometrial receptivity markers in a three-dimensional human endometrial cell culture model.
Meng CX; Andersson KL; Bentin-Ley U; Gemzell-Danielsson K; Lalitkumar PG
Fertil Steril; 2009 Jan; 91(1):256-64. PubMed ID: 18206148
[TBL] [Abstract][Full Text] [Related]
5. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system.
Critchley HO; Wang H; Kelly RW; Gebbie AE; Glasier AF
Hum Reprod; 1998 May; 13(5):1210-7. PubMed ID: 9647549
[TBL] [Abstract][Full Text] [Related]
6. Mifepristone for the prevention of breakthrough bleeding in new starters of depo-medroxyprogesterone acetate.
Jain JK; Nicosia AF; Nucatola DL; Lu JJ; Kuo J; Felix JC
Steroids; 2003 Nov; 68(10-13):1115-9. PubMed ID: 14668006
[TBL] [Abstract][Full Text] [Related]
7. Effects of mifepristone on endometrial receptivity.
Danielsson KG; Marions L; Bygdeman M
Steroids; 2003 Nov; 68(10-13):1069-75. PubMed ID: 14668000
[TBL] [Abstract][Full Text] [Related]
8. Effect of mifepristone on estrogen and progesterone receptors in human endometrial and endometriotic cells in vitro.
Jiang J; Wu RF; Wang ZH; Sun HC; Xu Z; Xiu HM
Fertil Steril; 2002 May; 77(5):995-1000. PubMed ID: 12009357
[TBL] [Abstract][Full Text] [Related]
9. Endometrial vasculature in Norplant users.
Rogers PA
Hum Reprod; 1996 Oct; 11 Suppl 2():45-50. PubMed ID: 8982745
[TBL] [Abstract][Full Text] [Related]
10. Effect of mifepristone and levonorgestrel on expression of steroid receptors in the human Fallopian tube.
Christow A; Sun X; Gemzell-Danielsson K
Mol Hum Reprod; 2002 Apr; 8(4):333-40. PubMed ID: 11912281
[TBL] [Abstract][Full Text] [Related]
11. The effects of an antiprogestin, mifepristone, and an antiestrogen, tamoxifen, on endometrial 17 beta-hydroxysteroid dehydrogenase and progestin and estrogen receptors during the luteal phase of the menstrual cycle: an immunohistochemical study.
Mäentausta O; Svalander P; Danielsson KG; Bygdeman M; Vihko R
J Clin Endocrinol Metab; 1993 Oct; 77(4):913-8. PubMed ID: 8408465
[TBL] [Abstract][Full Text] [Related]
12. Progesterone receptor in Norplant endometrium.
Lau TM; Witjaksono J; Rogers PA
Hum Reprod; 1996 Oct; 11 Suppl 2():90-4. PubMed ID: 8982750
[TBL] [Abstract][Full Text] [Related]
13. Progesterone receptor isoform B in the human fallopian tube and endometrium following mifepristone.
Sun X; Christow A; Marions L; Gemzell-Danielsson K
Contraception; 2003 Apr; 67(4):319-26. PubMed ID: 12684155
[TBL] [Abstract][Full Text] [Related]
14. Effect of two antiprogestins (mifepristone and onapristone) on endometrial factors of potential importance for implantation.
Cameron ST; Critchley HO; Buckley CH; Kelly RW; Baird DT
Fertil Steril; 1997 Jun; 67(6):1046-53. PubMed ID: 9176442
[TBL] [Abstract][Full Text] [Related]
15. Contraceptive use of antiprogestin.
Bygdeman M; Danielsson KG; Marions L; Swahn ML
Eur J Contracept Reprod Health Care; 1999 Jun; 4(2):103-7. PubMed ID: 10427485
[TBL] [Abstract][Full Text] [Related]
16. Biological mechanisms underlying the clinical effects of mifepristone (RU 486) on the endometrium.
Papp C; Schatz F; Krikun G; Hausknecht V; Lockwood CJ
Early Pregnancy (Cherry Hill); 2000 Oct; 4(4):230-9. PubMed ID: 11742418
[TBL] [Abstract][Full Text] [Related]
17. [The changes of sex steroid receptors and morphology in Norplant treated endometrium].
Wang G; Zheng S; Fan Z
Zhonghua Fu Chan Ke Za Zhi; 1998 Aug; 33(8):493-7. PubMed ID: 10806752
[TBL] [Abstract][Full Text] [Related]
18. [Effects of mifepristone on expression of estrogen receptor and progesterone receptor in cultured human eutopic and ectopic endometria].
Jiang J; Wu R; Wang Z
Zhonghua Fu Chan Ke Za Zhi; 2001 Apr; 36(4):218-21. PubMed ID: 11783365
[TBL] [Abstract][Full Text] [Related]
19. Effects of daily low dose mifepristone on endometrial maturation and proliferation.
Cameron ST; Critchley HO; Thong KJ; Buckley CH; Williams AR; Baird DT
Hum Reprod; 1996 Nov; 11(11):2518-26. PubMed ID: 8981147
[TBL] [Abstract][Full Text] [Related]
20. Endometrial effects of RU486 in primates--antiproliferative action despite signs of estrogen action and increased cyclin-B expression.
Heikinheimo O; Hsiu JG; Gordon K; Kim S; Williams RF; Gibbons WE; Hodgen GD
J Steroid Biochem Mol Biol; 1996 Oct; 59(2):179-90. PubMed ID: 9010333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
